UY28583A1 - Forma de presentación del naproxeno sodico - Google Patents
Forma de presentación del naproxeno sodicoInfo
- Publication number
- UY28583A1 UY28583A1 UY28583A UY28583A UY28583A1 UY 28583 A1 UY28583 A1 UY 28583A1 UY 28583 A UY28583 A UY 28583A UY 28583 A UY28583 A UY 28583A UY 28583 A1 UY28583 A1 UY 28583A1
- Authority
- UY
- Uruguay
- Prior art keywords
- weight
- naproxen
- sodium
- tablet core
- presentation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un comprimido no efervescente de naproxeno sódico, que consta de un núcleo de comprimido y si se desea de un revestimiento de azúcar o de una película, donde el núcleo del comprimido, respecto al peso del núcleo del comprimido, se compone de un 30 hasta de un 99% en peso de naproxeno sódico y de un 70 hasta de un 1% en peso de naproxeno sódico y de un 70 hasta de un 1% en peso de componente demateria auxiliar, incluyendo como mínimo una sustancia auxiliar básica, posee una dureza suficiente, es comparativamente pequno y conduce a un aumento del nivel de sangre especialmente rápido y con ello a una acción analgésica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH18482003 | 2003-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28583A1 true UY28583A1 (es) | 2005-05-31 |
Family
ID=34529359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28583A UY28583A1 (es) | 2003-10-30 | 2004-10-27 | Forma de presentación del naproxeno sodico |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070134317A1 (es) |
| EP (1) | EP1684728B1 (es) |
| JP (1) | JP2007509862A (es) |
| AR (1) | AR046213A1 (es) |
| AT (1) | ATE442840T1 (es) |
| BR (1) | BRPI0415624A (es) |
| CA (1) | CA2543709A1 (es) |
| CR (1) | CR8406A (es) |
| DE (1) | DE602004023220D1 (es) |
| EC (1) | ECSP066587A (es) |
| ES (1) | ES2333332T3 (es) |
| PA (1) | PA8616101A1 (es) |
| PE (1) | PE20050445A1 (es) |
| UY (1) | UY28583A1 (es) |
| WO (1) | WO2005041938A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008500288A (ja) * | 2004-05-28 | 2008-01-10 | イメイジノット ピーティーワイ エルティーディー | 経口治療用化合物の供給系 |
| WO2006100281A2 (en) | 2005-03-22 | 2006-09-28 | Losan Pharma Gmbh | Solubilized ibuprofen |
| CA2629904C (en) * | 2005-11-28 | 2018-07-10 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| GB201506755D0 (en) * | 2015-04-21 | 2015-06-03 | Reckitt Benckiser Llc | Novel pharmaceutical formulation |
| WO2017062997A1 (en) * | 2015-10-09 | 2017-04-13 | Reckitt Benckiser Llc | Pharmaceutical formulation |
| JP7163015B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 経口固形組成物 |
| JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
| US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| US5034416A (en) * | 1988-01-19 | 1991-07-23 | Smith Walton J | Carboxylic acid compositions |
| PT96229B (pt) * | 1989-12-22 | 1998-06-30 | Syntex Pharma Int | Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico |
| US5358717A (en) * | 1989-12-22 | 1994-10-25 | Syntex (U.S.A.) Inc. | Directly-compressible naproxen or naproxen sodium compositions |
| IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
| GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
| US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| JPH10298072A (ja) * | 1997-04-17 | 1998-11-10 | Panacea Biotec Ltd | 非ステロイド性抗炎症剤の遷移金属錯体 |
| NZ333474A (en) * | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
| US6165506A (en) * | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| US6383515B2 (en) * | 1999-05-28 | 2002-05-07 | Sawyer Maryjean | Solvent system for enhancing solubility |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2002083110A2 (en) * | 2001-04-10 | 2002-10-24 | Zagros Pharma, Inc. | Animal model for evaluating analgesics |
| US20020192161A1 (en) * | 2001-04-10 | 2002-12-19 | Fahkreddin Jamali | Animal model for evaluating analgesics |
-
2004
- 2004-10-27 PE PE2004001035A patent/PE20050445A1/es not_active Application Discontinuation
- 2004-10-27 UY UY28583A patent/UY28583A1/es not_active Application Discontinuation
- 2004-10-28 PA PA20048616101A patent/PA8616101A1/es unknown
- 2004-10-28 AR ARP040103936A patent/AR046213A1/es not_active Application Discontinuation
- 2004-10-29 EP EP04761983A patent/EP1684728B1/en active Active
- 2004-10-29 JP JP2006537031A patent/JP2007509862A/ja active Pending
- 2004-10-29 US US10/577,197 patent/US20070134317A1/en not_active Abandoned
- 2004-10-29 AT AT04761983T patent/ATE442840T1/de not_active IP Right Cessation
- 2004-10-29 ES ES04761983T patent/ES2333332T3/es active Active
- 2004-10-29 BR BRPI0415624-2A patent/BRPI0415624A/pt not_active IP Right Cessation
- 2004-10-29 DE DE602004023220T patent/DE602004023220D1/de active Active
- 2004-10-29 WO PCT/CH2004/000655 patent/WO2005041938A1/en active Application Filing
- 2004-10-29 CA CA000000008A patent/CA2543709A1/en not_active Abandoned
-
2006
- 2006-05-15 CR CR8406A patent/CR8406A/es not_active Application Discontinuation
- 2006-05-29 EC EC2006006587A patent/ECSP066587A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007509862A (ja) | 2007-04-19 |
| AR046213A1 (es) | 2005-11-30 |
| DE602004023220D1 (de) | 2009-10-29 |
| ATE442840T1 (de) | 2009-10-15 |
| WO2005041938A1 (en) | 2005-05-12 |
| ECSP066587A (es) | 2006-10-17 |
| CR8406A (es) | 2008-04-25 |
| ES2333332T3 (es) | 2010-02-19 |
| EP1684728A1 (en) | 2006-08-02 |
| EP1684728B1 (en) | 2009-09-16 |
| US20070134317A1 (en) | 2007-06-14 |
| BRPI0415624A (pt) | 2006-12-12 |
| CA2543709A1 (en) | 2005-05-12 |
| PA8616101A1 (es) | 2005-08-04 |
| PE20050445A1 (es) | 2005-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8406A (es) | Forma de administracion del naproxeno sodico | |
| ECSP055793A (es) | Forma de administración de ibuprofeno sódico | |
| UY29853A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas- | |
| UY28489A1 (es) | Glucopiranosiloxi-pirazoles, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparación | |
| CR9220A (es) | Terapia combinatoria para el tratamiento de la diabetes y de condiciones relacionadas con la misma o para el tratamiento de condiciones mejoradas aumentando un nivel de glp-1 en sangre. | |
| AR052190A1 (es) | Uso de clorantes de cianina para el diagnostico de enfermedades proliferativas | |
| AR054060A1 (es) | Forma de dosificacion farmaceutica unitaria | |
| CR9987A (es) | Compuestos de lactama y métodos de uso de los mismos | |
| AR051577A1 (es) | Derivados eter sustituidos por hexafluorisopropanol | |
| GT200600200A (es) | Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato | |
| CR10172A (es) | Uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de abuso y adicción de sustancias | |
| UY29872A1 (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas | |
| UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
| UY31403A1 (es) | "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos". | |
| CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
| DE602004004817D1 (de) | Myo-inositol hexaphosphat zur topischen verwendung | |
| CR11744A (es) | Formulacion liquida para deferiprona con gusto agradable al paladar | |
| CR9523A (es) | Tableta recubierta de azucar | |
| AR053691A1 (es) | Agentes endoparasiticidas | |
| UY31000A1 (es) | Oxoisoxazoles como inhibidores de lipasas y fosfolipasas | |
| UY29593A1 (es) | Derivados de azolopiridin-2-ona como inhibidores de lipasas y fosfolipasas | |
| UY29594A1 (es) | Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosfolipasas | |
| ECSP10010683A (es) | Una formulacion farmacéutica sólida | |
| BRPI0513257A (pt) | composição farmacêutica lìquida | |
| TWD195031S (zh) | Slippers (1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20160617 |